An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia

Leong, SR; Sukumaran, S; Hristopoulos, M; Totpal, K; Stainton, S; Lu, E; Wong, A; Tam, L; Newman, R; Vuillemenot, BR; Ellerman, D; Gu, C; Mathieu, M; Dennis, MS; Nguyen, A; Zheng, B; Zhang, C; Lee, G; Chu, YW; Prell, RA; Lin, KD; Laing, ST; Polson, A

Leong, SR; Polson, AG (reprint author), Genentech Inc, 1 DNA Way,MS 72A, San Francisco, CA 94080 USA.

BLOOD, 2017; 129 (5): 609

Abstract

Acute myeloid leukemia (AML) is a major unmet medical need. Most patients have poor long-term survival, and treatment has not significantly changed in......

Full Text Link